A Propensity Score Analysis Shows that Empirical Treatment with Linezolid Does Not Increase the Thirty-Day Mortality Rate in Patients with Gram-Negative Bacteremia

The role of linezolid in empirical therapy of suspected bacteremia remains unclear. The aim of this study was to evaluate the influence of empirical use of linezolid or glycopeptides in addition to other antibiotics on the 30-day mortality rates in patients with Gram-negative bacteremia. For this pu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Ternavasio-de la Vega, Hugo-Guillermo, Mateos-Díaz, Ana-María, Martinez, Jose-Antonio, Almela, Manel, Cobos-Trigueros, Nazaret, Morata, Laura, De-la-Calle, Cristina, Sala, Marta, Mensa, Josep, Marcos, Miguel, Soriano, Alex
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249502/
https://ncbi.nlm.nih.gov/pubmed/25199780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03796-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados